SEC Form 4 · accession 0001628280-18-012483

Guardant Health, Inc. · GH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners

10% Owner

10% Owner

10% Owner

10% Owner

Period of report

Oct 9, 2018

Accepted (ET)

Oct 11, 2018 · 4:29 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001576280

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
COMMON STOCK^F1,F2	Oct 9, 2018	C	1,016,995	—	A	1,016,995	I	By TLS Beta Pte. Ltd.
COMMON STOCK^F1,F2	Oct 9, 2018	C	596,012	—	A	596,012	I	By TLS Beta Pte. Ltd.

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
SERIES D PREFERRED STOCK^F1,F2	—	Oct 9, 2018	C	1,016,995	D	—	—	COMMON STOCK	1,016,995	0	I
SERIES E PREFERRED STOCK^F1,F2	—	Oct 9, 2018	C	596,012	D	—	—	COMMON STOCK	596,012	0	I

F1The shares of Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at the then-effective conversion rate for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Certificate of Incorporation) immediately prior to the consummation of the Issuer's initial public offering, and have no expiration date.
F2The shares are directly held by TLS Beta Pte. Ltd., which is a direct wholly-owned subsidiary of Temasek Life Sciences Private Limited. Temasek Life Sciences Private Limited is a direct wholly-owned subsidiary of Fullerton Management Pte Ltd, or FMPL, which in turn is a direct wholly-owned subsidiary of Temasek Holdings (Private) Limited. Temasek Life Sciences Private Limited, FMPL and Temasek Holdings (Private) Limited may therefore be deemed to have or share beneficial ownership of the securities held by TLS Beta Pte. Ltd.